July 2022 Preferred Drug List Updated
For additional information, click here.
Pharmacy Education Information and Opportunities
For additional information, click here.
NDC Requirements for the Submission of Clinician-Administered Drug Claims
For additional information, click here.
Revised VDP Manuals Available
For additional information, click here.
Agenda for January Drug Utilization Review Board Meeting Now Available
For additional information, click here.
Retroactive Claim Form Process Ending Dec. 31, 2022
For additional information, click here.
Revised VDP Manuals Available
For additional information, click here.
Clinical Prior Authorization for Calcitonin Gene-Related Peptide Receptor (CGRP) Antagonists in Traditional Medicaid Begins Dec. 30, 2022
For additional information, click here.
Genabio COVID-19 At-Home Test Kit Added to Formulary
For additional information, click here.
Semi-annual Medicaid Preferred Drug List Update Coming Jan. 26, 2023
For additional information, click here.
Hepatitis C Treatment Coverage and PDL Update Scheduled for Jan. 1, 2023
For additional information, click here.
Manufacturer Reminder For Properly Submitting Rebate Invoices
For additional information, click here.
Clinical Prior Authorization Assistance Chart Now Available
For additional information, click here.
Input on Proposed Medicaid, CHIP Formulary, PDL and Prior Authorization Management Transition Policy Due Dec. 4, 2022
For additional information, click here.
Revised VDP Manuals Available
For additional information, click here.
October 2022 Drug Utilization Review Board Meeting Summary
For additional information, click here.
New Report from HHSC
For additional information, click here.
CGRP Antagonist Prophylaxis Prior Authorization Revisions Scheduled for Nov. 22, 2022
For additional information, click here.
Revision to Cosentyx Clinical Prior Authorization Criteria Scheduled for Nov. 22, 2022
For additional information, click here.
October 2022 NDC-to-HCPCS Crosswalk Now Available
For additional information, click here.
Clinical Prior Authorization Criteria Revisions for Bylvay Scheduled for Nov. 21, 2022
For additional information, click here.
July 2022 Preferred Drug List Decisions Now Available
For additional information, click here.
Clinical Criteria Update for Orkambi Scheduled for Nov. 9, 2022
For additional information, click here.
Summer 2022 RSV Season Schedule
For additional information, click here.
RSV Fall/Winter Traditional Season Regional Changes Effective Oct. 17, 2022
For additional information, click here.
2022-23 RSV Season Schedule
For additional information, click here.
ProAir HFA Inhaler Discontinuation
For additional information, click here.
Revised VDP Manuals Available
For additional information, click here.
Pharmacy Education Reminder
For additional information, click here.
Agenda for October Drug Utilization Review Board Meeting Now Available
For additional information, click here.
PDL Prior Authorization Criteria Revisions Scheduled For Oct. 11, 2022
For additional information, click here.
Criteria Changes for Subsequent Dosing of Palivizumab (Synagis) with Fall/Winter Traditional Respiratory Syncytial Virus Season
For additional information, click here.
Temporary Change in PDL Status for Clonidine Transdermal Patches Effective Sept. 26, 2022
For additional information, click here.
Clinical Prior Authorization Criteria Revisions Implement for Medicaid Fee-for-Service On Oct. 26, 2022
For additional information, click here.
September 2022 Specialty Drug List Available
For additional information, click here.
Pharmacy Prior Authorization System Maintenance Scheduled for Monday, Oct. 3, 2022
For additional information, click here.
A Psychiatrist Sought for the Drug Utilization Review Board
For additional information click here.
Bivalent Moderna COVID-19 Booster Vaccine Coverage Update
For additional information click here.
Bivalent Pfizer COVID-19 Booster Vaccine Coverage Update
For additional information, click here.
Hepatitis C Treatment Coverage and PDL Update Scheduled for Jan. 1, 2023
For additional information, click here.
RSV Summer Season Changes Begin Sept. 1, 2022
For additional information, click here.
Draft Specialty Drug List Available for Comment, Responses Due Sept. 22, 2022
For additional information, click here.
July 2022 Preferred Drug List Updated
For additional information, click here.
Drug Regimen Optimization Clinical Prior Authorization to Retire Sept. 12, 2022
For additional information click here.
Clinical Prior Authorization Assistance Chart Now Available
For additional information, click here.
Clinical Prior Authorization for Xenical No Longer Required After Sept. 12, 2022
For additional information, click here.
Hepatitis C Treatment Coverage and PDL Update Scheduled for Sept. 1, 2022
For additional information, click here.
July 2022 Preferred Drug List Now Available
For additional information click here.
Revised VDP Manuals Available
For additional information click here.
July 2022 Drug Utilization Review Board Meeting Summary
For additional information click here.
EXTENDED: Members Sought for the Drug Utilization Review Board until Aug. 1, 2022
For additional information click here.
July 2022 NDC-to-HCPCS Crosswalk Now Available
For additional information click here.
Novavax COVID-19 Vaccine Coverage Update
For additional information click here.
Prior Authorization Criteria Update for Rinvoq and Cibinqo
For additional information click here.
Semi-annual Medicaid Preferred Drug List Update Coming July 28, 2022
For additional information click here.
April 2022 Preferred Drug List Decisions Now Available
For additional information click here.
Revised Application for Texas Identification Number Now Available for Pharmacy Enrollment
For additional information click here.
HHSC Pharmacy Prior Authorization System Maintenance Scheduled for Early Morning This Wednesday
For additional information click here.
HHSC to Reject Pharmacy Claims for Inaccurate License Information Beginning September 28, 2022
For additional information click here.
Agenda for July Drug Utilization Review Board Meeting Now Available
For additional information click here.
Revised VDP Manuals Available
For additional information click here.
Clinical Prior Authorization Criteria Updates for Dupixent, Evrysdi, and Qelbree
For additional information click here.
Pediatric Updates for Moderna & Pfizer-BioNTech COVID-19 Vaccines
For additional information click here.
COVID-19 Drug Veklury (Remdesivir) Update
For additional information, click here.
Clinical Prior Authorization Assistance Chart Now Available
For additional information, click here.
Summer 2022 RSV Season Schedule
For additional information, click here.
Pfizer COVID-19 Vaccine Booster Dose for Children Update
For additional information, click here.
Moderna COVID-19 Vaccine Booster Dose Update
For additional information, click here.
Respiratory Syncytial Virus (RSV) Prophylaxis Season Reopening Across All Regions
For additional information, click here.
Changes for Client Access to Mosquito Repellent Benefit Begin June 1, 2022
For additional information, click here.
Spikevax COVID-19 Vaccine Coverage Update
For additional information, click here.
Members Sought for the Drug Utilization Review Board
For more information please click here.
Changes for Client Access to Mosquito Repellent Benefit Begin June 1, 2022
For more information please click here.
Update to the Pharmacy Procedure Manual Now Available
For more information please click here.
Second COVID-19 Vaccine Booster Dose Update
For more information please click here.
Request for Pharmacies to Check That Pharmacy Licenses Are Current in PEMS
For more information please click here.
April 2022 Drug Utilization Review Board Meeting Summary
For more information please click here.
Revision to Makena Authorization Request Form Scheduled for June 10, 2022
For more information please click here.
January 2022 Preferred Drug List Decisions Now Available
For more information please click here.
Update to the Pharmacy Procedure Manual Now Available
For more information please click here.
March 2022 Specialty Drug List Available
For more information please click here.
Agenda for April Drug Utilization Review Board Meeting Now Available
For more information please click here.
Pharmacy Education Reminder
For more information please click here.
Changes for Client Access to Mosquito Repellent Benefit Begin June 1, 2022
For additional information click here.
Draft Specialty Drug List Available for Comment
For more information please click here.
Updates to Phosphate Binder Prior Authorization Criteria Scheduled for April 5, 2022
For more information please click here.
Cytokine and CAM Antagonists Criteria Updates Scheduled for April 5, 2022
For more information please click here.
Oxbryta Prior Authorization Criteria Updates Scheduled for April 5, 2022
For more information please click here.
January 2022 Drug Utilization Review Board Meeting Summary
For more information please click here.
Clinical Prior Authorization Assistance Chart Now Available
For more information please click here.
2021-22 Respiratory Syncytial Virus (RSV) Season Ends February 1, 2022
For more information please click here.
January 2022 Preferred Drug List Now Available
For more information please click here.
Temporary Change in PDL Status for Tetracyclines Drug Class, Effective January 11, 2022
For more information please click here.
Pfizer-BioNTech COVID-19 Booster Update
For more information please click here.
November 2021 Preferred Drug List Decisions Now Available
For more information please click here.
Pfizer-BioNTech COVID-19 Vaccine Booster Dose Age Change and New Formulation
For more information please click here.
Agenda for January Drug Utilization Review Board Meeting Now Available
For more information please click here.
Managed Care Resources Update
For more information please click here.
COVID-19 At-home Test Kits Available as a Pharmacy Benefit
For more information please click here.
Pfizer Oral COVID-19 Drug, Paxlovid, Added to Formulary
For more information please click here.
Medicaid Pharmacy Benefit Accredited Course, Quick Courses Available
For more information please click here.
You Can Report Drug Shortages to HHSC
For more information please click here.
Merck Oral COVID-19 drug, Molnupiravir, Added to Formulary
For more information please click here.